Cardiomyopathy Gene Panel in UAE | 4800 AED | 2026 DHA Guidelines

تحليل لوحة جينات اعتلال عضلة القلب في الإمارات | 4800 درهم | معتمد من هيئة الصحة بدبي

Executive Summary

الملخص التنفيذي: تحليل جيني شامل بدقة تشخيصية 99.9% مع خدمة سحب منزلي مبرد معتمدة، وإرشاد طبي هاتفي بعد الفحص.

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited Next‑Generation Sequencing.
Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).
Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation by a DHA‑licensed specialist.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview

The Cardiomyopathy Gene Panel is a comprehensive Next‑Generation Sequencing (NGS) assay that simultaneously analyzes more than 70 genes linked to inherited cardiomyopathies, delivering definitive molecular insights for tailored cardiac care. (تحليل جيني شامل لأكثر من 70 جينًا مرتبطًا باعتلال عضلة القلب الوراثي باستخدام تقنية التسلسل المتقدم.)

Feature	Our Test	Closest Alternative
Precision	99.9% Analytical Sensitivity (NGS)	~95% (Sanger‑based limited panels)
Method	NGS with full exon coverage & copy number variant detection	Single‑gene or small multi‑gene Sanger sequencing
Turnaround	4–6 Weeks	8–12 Weeks

Physician Insight & Safety Protocol

“A cardiomyopathy gene panel is a powerful tool for identifying hereditary disease predisposition, but a negative result does not exclude all genetic etiologies. I always interpret the report alongside family history, ECG, and echocardiographic findings. Clinical correlation remains paramount.” – Dr. Prabhakar Reddy, DHA License: 61713011

⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor. Genetic test results should be reviewed by a cardiologist or clinical geneticist before any change in management.

Safety Exclusion Criteria & Emergency Red Flags

Exclusion: Active febrile illness or acute decompensated heart failure – resample after stabilization.
Exclusion: Inability to provide at least 2 mL of peripheral blood / chorionic villi / amniotic fluid.
ER Red Flags: Sudden chest pain, syncope, or sustained ventricular tachycardia while awaiting results – seek immediate emergency care.
Minor Consent: For patients under 18, parental/legal guardian consent and a paediatric cardiologist referral are mandatory per UAE CDS Law 2026.

Patient FAQ & Clinical Guidance

What is the cardiomyopathy gene panel and who should consider it?

A cardiomyopathy gene panel is a comprehensive genetic test that analyses more than 70 genes linked to inherited heart muscle diseases. It is recommended for individuals with a family history of cardiomyopathy, unexplained heart failure, or sudden cardiac death at a young age.

لوحة جينات اعتلال عضلة القلب هي فحص جيني شامل يحلل أكثر من 70 جينًا مرتبطًا بأمراض عضلة القلب الوراثية. يُنصح به لمن لديهم تاريخ عائلي باعتلال عضلة القلب أو قصور قلب غير مفسر أو وفاة قلبية مفاجئة في سن مبكرة.

How is the sample collected and what is the turnaround time?

A sample of peripheral blood, amniotic fluid, or chorionic villi is collected by a certified phlebotomist at your home or in a clinic. Results are typically ready in 4 to 6 weeks after the laboratory receives the sample.

يتم جمع العينة (دم طرفي، سائل سلوي أو زغابات مشيمية) بواسطة فني معتمد في المنزل أو العيادة. تظهر النتائج عادةً خلال 4 إلى 6 أسابيع من استلام المختبر للعينة.

What happens if a variant of uncertain significance (VUS) is found?

A variant of uncertain significance means the genetic change’s effect on heart muscle function is not yet clearly understood. Your cardiologist may recommend periodic re‑evaluation of the result as scientific knowledge advances, and clinical decisions should be based on the overall picture.

المتغير غير محدد الأهمية يعني أن تأثير التغير الجيني على وظيفة عضلة القلب غير واضح بعد. قد يوصي طبيب القلب بإعادة تقييم النتيجة دوريًا مع تطور العلم، ويجب أن تستند القرارات السريرية للصورة الكاملة.

UAE Regulatory Compliance

This service adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87), UAE PDPL for genetic data privacy, and CDS Law 2026 for minors. Laboratory accredited under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). Facility License: 9834453.

Pre‑ information: A valid doctor’s prescription is required; prescription may be waived for surgical clearance, pregnancy, or pre‑travel screening.

دعم ثنائي اللغة متاح